Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model.
Dighe, S.N., de la Mora, E., Chan, S., Kantham, S., McColl, M., Veliyath, S.K., Miles, J.A., Nessar, Z., McGeary, R.P., Silman, I., Parat, M.O., Weik, M., Brazzolotto, X., Ros, B.P.(2019) Commun Chem